ClinicalTrials.gg
CompletedNCT07696780DESTINYUpdated Jul 10, 2026

Diabetes Management Among Women Using an AID System: a Mixed Method Study

An observational study in Type 1 Diabetes, sponsored by DCB Research AG. Completed at 1 site in Switzerland. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-10.

Sponsored by DCB Research AG · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
69
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 70 studies in Diabetes Mellitus, Type 1 with a site in Switzerland — 9 open to participants now, 10 under way, 4 of them phase 3. Diabetes Mellitus, Type 1 · Switzerland.

Enrollment
10th of 18
69 · median 73
Started
2024
the only one that year
Observational
18 of 70
4 open now
Registered
70th of 70
by date
Lead sponsor
3 of 70
DCB Research AG

Among the 70 studies in Diabetes Mellitus, Type 1 with a site in Switzerland, this one is the 10th largest by enrollment of the 18 observational ones that give a count, is the only one that started in 2024, is one of 18 observational ones, and was the 70th registered.

Diabetes Mellitus, Type 1

3,758 studies on the registry are indexed under Diabetes Mellitus, Type 1; 600 are open to participants now.

Browse Diabetes Mellitus, Type 1 studies →

Open to participants now

9 of the 70 studies in Diabetes Mellitus, Type 1 with a site in Switzerland are open now. Recruiting first, the newest first:

4 more — sign in →

All 9 open studies →

A study can be open while its sites in Switzerland have not opened yet or have stopped. Only those recruiting at a site in Switzerland →

Who these studies take

Of the 417 Diabetes Mellitus, Type 1 studies recruiting now, 130 (31%) set no upper age limit and 261 (63%) stop at 75 or younger; 187 take children under 18; 66 take healthy volunteers.

This study: 18 Years and older · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 70 studies in Diabetes Mellitus, Type 1 with a site in Switzerland, or all of them as a file.
02

Study summary

Automated insulin delivery (AID) systems substantially improve diabetes management in people with type 1 diabetes but do not account for menstrual cycle related changes in insulin sensitivity. As a result, many menstruating individuals rely on manual adjustments, such as entering fake carbohydrates, modifying insulin settings, or changing basal rates, to maintain glycemic control. This study aims to systematically characterize these manual adjustment strategies, estimate how frequently they are used across the menstrual cycle, and explore their perceived burden, effectiveness, and implications for the development of future AID algorithms that better address menstrual cycle related insulin variability.

Read the detailed description

Background Automated insulin delivery (AID) systems are expected to substantially improve diabetes management in people with type 1 diabetes but do not account for menstrual cycle related changes in insulin sensitivity, leading many menstruating individuals to rely on manual adjustments such as modifying insulin settings or entering "fake carbohydrates" to maintain glycemic control. This study will address the limited evidence in this area by systematically characterizing the range of manual adjustment strategies used across the menstrual cycle to inform the development of future AID systems.

Methods A mixed methods study design will be used, comprising an online survey followed by semi structured online focus groups with a subset of survey participants. The survey will capture self reported manual adjustment practices, while the focus groups will explore these strategies in greater depth through participant discussions to better understand the range, rationale, and variation of approaches used across the menstrual cycle.

Objectives The primary objective will be to identify and characterize manual adjustment strategies used by menstruating individuals with type 1 diabetes to compensate for menstrual cycle related changes in insulin requirements while using automated insulin delivery systems. Secondary objectives will include assessing the frequency, perceived burden and effectiveness of these strategies, their variation across the menstrual cycle, and identifying user needs to inform the development of future AID systems.

Outcomes Primary endpoints will be user reported manual adjustment strategies and perceptions of AID system use across the menstrual cycle. Secondary endpoints will include the frequency and perceived effectiveness of these strategies, user needs and preferences for AID systems, satisfaction with current system responsiveness, and the impact of menstrual cycle related adjustments on daily life.

Procedures Participants will be recruited through social media and partner networks and will complete an online REDCap survey that includes eligibility screening, informed consent, and collection of baseline characteristics, diabetes management, and menstrual cycle information. Eligible and interested participants will be invited to semi structured online focus groups (approximately five participants per group) to discuss manual adjustment strategies used during the menstrual cycle.

Statistical analysis No formal sample size calculation will be performed for the quantitative survey. Focus group data will be collected until thematic saturation is reached and will be analysed using thematic content analysis in Atlas.ti, involving transcription, coding, development of themes, and exploration of recurring patterns and relationships in manual adjustment strategies. Quantitative data will be analysed using R and Python.

03

Conditions studied

  • Type 1 Diabetes

Keywords

  • Menstrual cycle
  • Manual adjustments
  • Women's health
  • Mixed methods
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Women with type 1 diabetes and menstrual cycle using AID system

Eligibility criteria

Inclusion Criteria:

  • At least 18 years old
  • Good knowledge of English or German
  • Type 1 diabetes since >3 years
  • Regular menstrual cycle (24-35 days) since >2 years
  • Using one of the following AID systems: Tandem t-slim:X2 with Control-IQ; Medtronic 780G; DBLG1 (Kaleido, AkkuChek Insight); CAMAPS FX (Ypsopump, Dana); Omnipod 5; AAPS DIY; IAPS DIY; Loop DIY
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
69 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Type of manual adjustment to AID settings to manage menstrual cycle related changes in insulin requirement

    Semi-structured interviews will be analyzed using reflexive thematic analysis. Participant-reported strategies used to adjust AID system behavior in response to menstrual cycle-related changes in insulin requirements will be coded into themes (e.g., fictitious carbohydrate entries, temporary glucose targets, manual boluses, profile changes). The number of participants reporting each strategy will be summarized descriptively.

    Time frame: One full menstrual cycle (24 - 35 days)

Secondary outcomes

  1. Frequency of manual adjustments across the menstrual cycle

    Identify frequencies of manual adjustments applied by the participants

    Time frame: One full menstrual cycle (24 - 35 days)

  2. Perceived burden related to manual adjustments (scale 1 - 5)

    Perception of burden related to manual adjustments which are related to the menstrual cycle

    Time frame: One full menstrual cycle (24 - 35 days)

  3. Self-reported assessment of effectiveness of manual adjustment strategies on glucose control

    Participants' self reported perception of how well manual adjustment strategies help maintain glycemic control and support diabetes management during different phases of the menstrual cycle.

    Time frame: One full menstrual cycle (24 - 35 days)

07

Study locations

1 site
  • DCB Research AG
    Bern, Canton of Bern 3010, Switzerland
08

References and documents

Individual participant data

Plan to share: Undecided — All data extracted from the recordings can be found in the manuscript on the study.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2024 to primary completion in Feb 2025, 4 months.

Of 248 non-industry observational studies under Diabetes Mellitus, Type 1, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 78. This study's 4 months is below that.

Counting every sponsor, half of 298 studies reached it within 28 months; a quarter within 12 and three quarters within 69.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 30, 2026
First posted
Jul 10, 2026
StartActual
Oct 1, 2024
Primary completionActual
Feb 1, 2025
CompletionActual
Feb 1, 2025
Last update
Jul 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07696780
Lead sponsor
DCB Research AG
Responsible party
Sponsor
First posted
Jul 10, 2026
Start date
Oct 1, 2024
Primary completion
Feb 1, 2025
Completion
Feb 1, 2025
Last update
Jul 10, 2026

Study contacts

Martina Rothenbühler
principal investigator · DCB Research AG

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion